Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.
Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.
ACS Appl Mater Interfaces. 2023 Nov 1;15(43):49988-50001. doi: 10.1021/acsami.3c09399. Epub 2023 Oct 20.
Cell surface receptors facilitate signaling and nutrient uptake. These processes are dynamic, requiring receptors to be actively recycled by endocytosis. Due to their differential expression in disease states, receptors are often the target of drug-carrier particles, which are adorned with ligands that bind specifically to receptors. These targeted particles are taken into the cell by multiple routes of internalization, where the best-characterized pathway is clathrin-mediated endocytosis. Most studies of particle uptake have utilized bulk assays rather than observing individual endocytic events. As a result, the detailed mechanisms of particle uptake remain obscure. To address this gap, we employed a live-cell imaging approach to study the uptake of individual liposomes as they interact with clathrin-coated structures. By tracking individual internalization events, we find that the size of liposomes rather than the density of the ligands on their surfaces primarily determines their probability of uptake. Interestingly, targeting has the greatest impact on endocytosis of liposomes of intermediate diameters, with the smallest and largest liposomes being internalized or excluded, respectively, regardless of whether they are targeted. These findings, which highlight a previously unexplored limitation of targeted delivery, can be used to design more effective drug carriers.
细胞表面受体促进信号转导和营养物质摄取。这些过程是动态的,需要受体通过内吞作用被主动回收。由于它们在疾病状态下的差异表达,受体通常是药物载体颗粒的靶标,这些颗粒被缀合到与受体特异性结合的配体上。这些靶向颗粒通过多种内化途径被细胞摄取,其中研究最充分的途径是网格蛋白介导的内吞作用。大多数关于颗粒摄取的研究都使用了批量测定法,而不是观察单个内吞事件。因此,颗粒摄取的详细机制仍然不清楚。为了解决这一差距,我们采用了活细胞成像方法来研究单个脂质体与网格蛋白包被结构相互作用时的摄取情况。通过跟踪单个内化事件,我们发现脂质体的大小而不是其表面配体的密度主要决定了它们被摄取的概率。有趣的是,靶向作用对中等直径脂质体的内吞作用影响最大,最小和最大的脂质体分别被内化或排除,而不管它们是否被靶向。这些发现突出了靶向递送的一个以前未被探索的限制,可用于设计更有效的药物载体。